CDTX - Cidara Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $177.88 DETAILS

Stock News

Cidara Therapeutics (NASDAQ:CDTX) Stock Price Passes Above Fifty Day Moving Average – Should You Sell?

Cidara Therapeutics, Inc. (NASDAQ: CDTX - Get Free Report) shares crossed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $220.52 and traded as high as $221.41. Cidara Therapeutics shares last traded at $221.38, with a volume of 2,691,000 shares. Analysts Set New Price Targets CDTX has

Jan 23, 2026 10:32 PM • defenseworld.net

Price Targets

CDTX - Cidara Therapeutics, Inc.

Stock News

Cidara Therapeutics (NASDAQ:CDTX) Stock Price Passes Above Fifty Day Moving Average – Should You Sell?

Price Targets

Cidara downgraded to Sector Perform from Outperform at RBC Capital

Cidara Therapeutics price target raised to $150 from $110 at H.C. Wainwright

Cidara Therapeutics price target raised to $173 from $153 at Citizens JMP

Cidara Therapeutics price target raised to $110 from $74 at H.C. Wainwright

Cidara Therapeutics price target raised to $153 from $66 at Citizens JMP

Cidara Therapeutics price target raised to $167 from $70 at Guggenheim

Cidara Therapeutics price target raised to $137 from $115 at RBC Capital

Cidara Therapeutics (CDTX) PT Raised to $69 at Guggenheim

Cidara Therapeutics price target raised to $68 from $50 at Guggenheim

Cidara Therapeutics price target raised to $50 from $35 at Guggenheim

Cidara Therapeutics initiated with an Outperform at Citizens JMP

H.C. Wainwright Upgrades Cidara Therapeutics (CDTX) to Buy